Immunomedics, Inc.

  • Pharmaceutical Manufacturing Technologist (2nd shift)

    Job Locations US-NJ-Morris Plains
    Posted Date 2 months ago(5/2/2018 3:00 PM)
    Job ID
    # of Openings
    Scientific Manufacturing/Production
  • Overview

    We are seeking a Pharmaceutical Manufacturing Technologist to be responsible for the manufacturing of clinical products in compliance with current Good Manufacturing Practice (cGMP) and Standard Operating Procedures (SOPs).


    Primary schedule will run Monday through Friday second shift 1 PM-9:30 PM 


    • Prepare buffers (up to 200L each).
    • Manufacture antibodies, antibody fragments, and conjugates.
    • Purify antibodies using ion-exchange, affinity column chromatography, and DV20 Virus Removal Filtration.
    • Maintain inventory of raw materials and supplies needed in manufacturing.
    • Maintain accurate batch records, log books, and log sheets.
    • Write/revise batch records, buffer sheets, SOPs, and Material Specification Sheets (MSSs).
    • Fill Bulk Drug Substance aseptically.
    • Maintain and calibrate daily all equipment needed during production.
    • Monitor and assure adequate supply of glassware/components for manufacturing.



    • Bachelor’s degree in biology, chemistry, or related discipline and strong aseptic technique are required.
    • Open to entry level candidates, but strong preference will be given to those who offer prior clean room/industrial purification experience.
    • Ability to follow SOPs and cGMP guidelines and regulations is required. 
    • Must possess excellent communication (oral and written) and interpersonal skills. 
    • Detail oriented with strong organizational, follow-through, and problem-solving skills.
    • Must be able to work collaborativelin a team environment
    • Must be proficient with MS Office applications. 


    Hourly pay rate commensurate with experience, plus a comprehensive benefit program. 



    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed